| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 5 | US FAERS | |
| 2 | Tenofovir | FAERS: 5 | US FAERS | |
| 3 | Acyclovir | FAERS: 2 | US FAERS | |
| 4 | Cetirizine | FAERS: 1 | US FAERS | |
| 5 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 6 | Doxycycline | FAERS: 1 | US FAERS | |
| 7 | Gefitinib | FAERS: 1 | US FAERS | |
| 8 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 9 | Naltrexone | FAERS: 1 | US FAERS | |
| 10 | NuvaRing | FAERS: 1 | US FAERS | |
| 11 | Paroxetine | FAERS: 1 | US FAERS | |
| 12 | Rifampin | FAERS: 1 | US FAERS | |
| 13 | Risedronic Acid | FAERS: 1 | US FAERS | |
| 14 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 15 | tofacitinib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.